Try our beta test site
1 study found for:    Siegel Waldenstrom's
Show Display Options
Rank Status Study
1 Recruiting A Phase 1 Study Evaluating CB-5083 in Subjects With Lymphoid Hematological Malignancies
Conditions: Lymphoid Hematological Malignancies;   Relapsed and Refractory Multiple Myeloma
Interventions: Drug: CB-5083;   Drug: Dexamethasone

Study has passed its completion date and status has not been verified in more than two years.